| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3849751 | American Journal of Kidney Diseases | 2011 | 11 Pages |
Abstract
An increase in MAP during vasoconstrictor therapy in patients with HRS is associated with improvement in kidney function across the spectrum of drugs tested to date. These results support consideration for a goal-directed approach to the treatment of HRS.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Juan Carlos Q. MD, Paul J. PhD,